Dry eye disease - ciclosporin (after artificial tears) [ID665]: committee papers
Table of contents
01 - Pre-Meeting Briefing prepared by NICE
02 - Submission from the technology manufacturer - Santen GmBH
03 - NICE request to the manufacturer for clarification on their submission
04 - NICE request for further clarification, additional question from the ERG
05 - Manufacturer clarification response
06 - Consultee submission - Royal College of Nursing
07 - Clinical expert personal perspective - Boboridis
08 - Clinical expert personal perspective - Figueiredo
09 - Evidence Review Group report prepared by Liverpool Reviews and Implementation group (LRiG)
10 - Manufacturer factual accuracy check of Evidence Review Group report
11 - Evidence Review Group erratum prepared by Liverpool Reviews and Implementation group (LRiG)
Dry eye disease - ciclosporin (after artificial tears) [ID665]: committee papers
24 June 2015 (7.13 Mb 25 sec) |
This page was last updated: 22 June 2015